Literature DB >> 22583442

Multiple sclerosis: risk factors and their interactions.

Giulio Disanto1, Julia M Morahan, Sreeram V Ramagopalan.   

Abstract

Multiple sclerosis (MS) is a highly debilitating immune mediated disorder of the central nervous system and represents a substantial burden to the developed world. Despite the recent advances in MS research, which risk factors are implicated and how they contribute to MS pathogenesis is largely unknown. However, in line with older studies investigating the genetic and geographical epidemiology of this complex disease, more recent studies have highlighted how MS arises from a combination of genetic susceptibility and environmental exposures acting from gestation to early adulthood. Vitamin D deficiency, season of birth, Epstein Barr virus infection, and smoking behaviour are strongly implicated and able to influence genetic predisposition to MS. Furthermore, these factors appear to act synergistically and the risk of MS in individuals exposed to more than one factor combines multiplicatively. Current evidence suggests that a large part of MS could be prevented and understanding how and when during life risk factors act will ultimately aid the development of prevention strategies.

Entities:  

Mesh:

Year:  2012        PMID: 22583442     DOI: 10.2174/187152712801661266

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  26 in total

1.  Modeling month-season of birth as a risk factor in mouse models of chronic disease: from multiple sclerosis to autoimmune encephalomyelitis.

Authors:  Jacob D Reynolds; Laure K Case; Dimitry N Krementsov; Abbas Raza; Rose Bartiss; Cory Teuscher
Journal:  FASEB J       Date:  2017-03-14       Impact factor: 5.191

2.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

3.  The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.

Authors:  Jameson P Holloman; Calvin C Ho; Arushi Hukki; Jennifer L Huntley; G Ian Gallicano
Journal:  Am J Stem Cells       Date:  2013-06-30

4.  Prevalence of sea, seb, sec, sed, and tsst-1 genes of Staphylococcus aureus in nasal carriage and their association with multiple sclerosis.

Authors:  Zahra Pakbaz; Mohammad Ali Sahraian; Samira Sabzi; Mahmood Mahmoodi; Mohammad Reza Pourmand
Journal:  Germs       Date:  2017-12-05

5.  Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments.

Authors:  Shekoufeh Nikfar; Abbas Kebriaeezadeh; Rassoul Dinarvand; Mohammad Abdollahi; Mohammad-Ali Sahraian; David Henry; Ali Akbari Sari
Journal:  Daru       Date:  2013-06-22       Impact factor: 3.117

6.  Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.

Authors:  Theresa L Montgomery; Axel Künstner; Josephine J Kennedy; Qian Fang; Lori Asarian; Rachel Culp-Hill; Angelo D'Alessandro; Cory Teuscher; Hauke Busch; Dimitry N Krementsov
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-19       Impact factor: 11.205

7.  Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties.

Authors:  Daniel Golan; Basheer Halhal; Lea Glass-Marmor; Elsebeth Staun-Ram; Orit Rozenberg; Idit Lavi; Sara Dishon; Mira Barak; Sophia Ish-Shalom; Ariel Miller
Journal:  BMC Neurol       Date:  2013-06-14       Impact factor: 2.474

Review 8.  Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.

Authors:  Carole Lunny; Jennifer A Knopp-Sihota; Shawn N Fraser
Journal:  BMC Neurol       Date:  2013-05-06       Impact factor: 2.474

9.  The relation between Vitamin D status with fatigue and depressive symptoms of multiple sclerosis.

Authors:  Fereshteh Ashtari; Masoomeh Ajalli; Vahid Shaygannejad; Mojtaba Akbari; Silva Hovsepian
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

Review 10.  Multiple sclerosis in children.

Authors:  Soroor Inaloo; Saideh Haghbin
Journal:  Iran J Child Neurol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.